Hubbell Inc has a consensus price target of $351.45 based on the ratings of 12 analysts. The high is $450 issued by Mizuho on March 20, 2024. The low is $225 issued by Wells Fargo on February 1, 2023. The 3 most-recent analyst ratings were released by Barclays, Wells Fargo, and Barclays on May 2, 2024, May 1, 2024, and April 2, 2024, respectively. With an average price target of $393.67 between Barclays, Wells Fargo, and Barclays, there's an implied 7.24% upside for Hubbell Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/02/2024 | Buy Now | 4.61% | Barclays | Julian Mitchell | $400 → $384 | Maintains | Equal-Weight | Get Alert |
05/01/2024 | Buy Now | 8.15% | Wells Fargo | Joseph O'Dea | $435 → $397 | Maintains | Equal-Weight | Get Alert |
04/02/2024 | Buy Now | 8.97% | Barclays | Julian Mitchell | $340 → $400 | Maintains | Equal-Weight | Get Alert |
03/20/2024 | Buy Now | 22.59% | Mizuho | Brett Linzey | $370 → $450 | Maintains | Buy | Get Alert |
03/11/2024 | Buy Now | 16.32% | Deutsche Bank | Nicole Deblase | → $427 | Initiates | → Hold | Get Alert |
01/31/2024 | Buy Now | -1.93% | Wells Fargo | Joseph O'Dea | $351 → $360 | Maintains | Equal-Weight | Get Alert |
01/31/2024 | Buy Now | -7.38% | Barclays | Julian Mitchell | $330 → $340 | Maintains | Equal-Weight | Get Alert |
12/19/2023 | Buy Now | -4.38% | Wells Fargo | Joseph O'Dea | $300 → $351 | Maintains | Equal-Weight | Get Alert |
12/08/2023 | Buy Now | -7.92% | TD Cowen | Nick Amicucci | → $338 | Initiates | → Outperform | Get Alert |
12/04/2023 | Buy Now | -11.47% | Barclays | Julian Mitchell | → $325 | Initiates | → Equal-Weight | Get Alert |
11/17/2023 | Buy Now | -8.74% | JP Morgan | Stephen Tusa | $333 → $335 | Upgrade | Neutral → Overweight | Get Alert |
11/08/2023 | Buy Now | -11.47% | Seaport Global | Scott Graham | → $325 | Initiates | → Buy | Get Alert |
11/01/2023 | Buy Now | 2.15% | Stephens & Co. | Tommy Moll | → $375 | Reiterates | Overweight → Overweight | Get Alert |
08/11/2023 | Buy Now | — | Wolfe Research | Nigel Coe | — | Upgrade | Underperform → Peer Perform | Get Alert |
07/26/2023 | Buy Now | 2.15% | Stephens & Co. | Tommy Moll | → $375 | Reiterates | Overweight → Overweight | Get Alert |
07/26/2023 | Buy Now | -1.93% | Morgan Stanley | Joshua Pokrzywinski | $330 → $360 | Maintains | Equal-Weight | Get Alert |
07/12/2023 | Buy Now | -10.1% | Morgan Stanley | Joshua Pokrzywinski | $275 → $330 | Maintains | Equal-Weight | Get Alert |
07/10/2023 | Buy Now | -13.37% | Wells Fargo | Joseph O'Dea | $287 → $318 | Maintains | Equal-Weight | Get Alert |
05/16/2023 | Buy Now | -31.9% | UBS | Chris Snyder | $215 → $250 | Maintains | Sell | Get Alert |
04/26/2023 | Buy Now | -25.09% | Morgan Stanley | Joshua Pokrzywinski | $238 → $275 | Maintains | Equal-Weight | Get Alert |
04/26/2023 | Buy Now | -18.28% | Mizuho | Brett Linzey | $252 → $300 | Maintains | Buy | Get Alert |
04/13/2023 | Buy Now | -39.8% | Wells Fargo | Joseph O'Dea | $225 → $221 | Maintains | Equal-Weight | Get Alert |
02/01/2023 | Buy Now | -35.17% | Morgan Stanley | Joshua Pokrzywinski | $226 → $238 | Maintains | Equal-Weight | Get Alert |
02/01/2023 | Buy Now | -38.71% | Wells Fargo | Joe O'Dea | $221 → $225 | Maintains | Equal-Weight | Get Alert |
02/01/2023 | Buy Now | -44.16% | JP Morgan | Stephen Tusa | → $205 | Upgrade | Underweight → Neutral | Get Alert |
01/19/2023 | Buy Now | -39.8% | Wells Fargo | Joe O'Dea | $222 → $221 | Maintains | Equal-Weight | Get Alert |
01/05/2023 | Buy Now | -39.52% | Wells Fargo | Joe O'Dea | $215 → $222 | Maintains | Equal-Weight | Get Alert |
01/04/2023 | Buy Now | -38.71% | UBS | Chris Snyder | $254 → $225 | Downgrade | Neutral → Sell | Get Alert |
12/01/2022 | Buy Now | -35.98% | Wolfe Research | Nigel Coe | → $235 | Downgrade | Peer Perform → Underperform | Get Alert |
11/17/2022 | Buy Now | -30.81% | UBS | Chris Snyder | $200 → $254 | Maintains | Neutral | Get Alert |
10/27/2022 | Buy Now | -41.43% | Wells Fargo | Joseph O'Dea | $196 → $215 | Maintains | Equal-Weight | Get Alert |
10/26/2022 | Buy Now | -38.43% | Morgan Stanley | Joshua Pokrzywinski | $219 → $226 | Maintains | Equal-Weight | Get Alert |
10/26/2022 | Buy Now | -31.35% | Mizuho | Brett Linzey | $220 → $252 | Maintains | Buy | Get Alert |
10/19/2022 | Buy Now | — | JP Morgan | Stephen Tusa | — | Downgrade | Overweight → Underweight | Get Alert |
10/12/2022 | Buy Now | -40.34% | Morgan Stanley | Joshua Pokrzywinski | $206 → $219 | Maintains | Equal-Weight | Get Alert |
07/27/2022 | Buy Now | -43.88% | Morgan Stanley | Joshua Pokrzywinski | $190 → $206 | Maintains | Equal-Weight | Get Alert |
06/29/2022 | Buy Now | -48.79% | Wells Fargo | Joseph O'Dea | $200 → $188 | Maintains | Equal-Weight | Get Alert |
05/31/2022 | Buy Now | -48.24% | Morgan Stanley | Joshua Pokrzywinski | $200 → $190 | Maintains | Equal-Weight | Get Alert |
04/28/2022 | Buy Now | -45.52% | Wells Fargo | Joseph O'Dea | $181 → $200 | Maintains | Equal-Weight | Get Alert |
04/07/2022 | Buy Now | -45.52% | Morgan Stanley | Joshua Pokrzywinski | $198 → $200 | Maintains | Equal-Weight | Get Alert |
03/01/2022 | Buy Now | -46.06% | Morgan Stanley | Joshua Pokrzywinski | $207 → $198 | Maintains | Equal-Weight | Get Alert |
02/07/2022 | Buy Now | -40.07% | Mizuho | Brett Linzey | $240 → $220 | Maintains | Buy | Get Alert |
01/14/2022 | Buy Now | -43.61% | Morgan Stanley | Joshua Pokrzywinski | $209 → $207 | Maintains | Equal-Weight | Get Alert |
12/17/2021 | Buy Now | -34.62% | Mizuho | Brett Linzey | — | Initiates | → Buy | Get Alert |
10/08/2021 | Buy Now | -47.7% | Wells Fargo | Joseph O'Dea | — | Initiates | → Equal-Weight | Get Alert |
10/07/2021 | Buy Now | -43.07% | Morgan Stanley | Joshua Pokrzywinski | — | Maintains | Equal-Weight | Get Alert |
07/28/2021 | Buy Now | -42.52% | Morgan Stanley | Joshua Pokrzywinski | — | Maintains | Equal-Weight | Get Alert |
The latest price target for Hubbell (NYSE:HUBB) was reported by Barclays on May 2, 2024. The analyst firm set a price target for $384.00 expecting HUBB to rise to within 12 months (a possible 4.61% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Hubbell (NYSE:HUBB) was provided by Barclays, and Hubbell maintained their equal-weight rating.
The last upgrade for Hubbell Inc happened on November 17, 2023 when JP Morgan raised their price target to $335. JP Morgan previously had a neutral for Hubbell Inc.
The last downgrade for Hubbell Inc happened on January 4, 2023 when UBS changed their price target from $254 to $225 for Hubbell Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hubbell, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hubbell was filed on May 2, 2024 so you should expect the next rating to be made available sometime around May 2, 2025.
While ratings are subjective and will change, the latest Hubbell (HUBB) rating was a maintained with a price target of $400.00 to $384.00. The current price Hubbell (HUBB) is trading at is $367.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.